Since the introduction of the 64 multi-slice CT scanner, studies have examined the utility of this technology for diagnosing coronary artery disease (CAD), and cardiologists are rapidly adopting this technology to perform CT Angiography (CTA) for detecting CAD.

iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the debate over which stent designs and stenting techniques are most effective.

Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES may be associated with increased risk of late-stent thrombosis have many physicians putting the brakes on DES use. Despite this significant bump in the road, stent manufacturers are forging ahead with clinical trials on novel systems and on plans to roll out new DES platforms in 2008.